Can the evolution of an enzyme be filmed in real time?
AI-generated hypothesis · Pre-publication · To be tested experimentally
Table of contents — full brief
- Hypothesis and mechanismCausal chain, key assumptions, residual unknowns
- State of the artVerified references and counter-evidence (DOIs)
- Falsifiable predictionsQuantitative bounds, statistical tests, H0
- Experimental protocolThree phases — in silico → minimal → full
- Impact analysisNovelty, residual gaps, available data
- Panel reviewFive personas + meta-review
Verified references
5 of 6 references- DOI: 10.1101/2025.03.30.646233 ↗
Biophysical fitness landscape design traps viral evolution
2025 - DOI: 10.1126/science.aaw2900 ↗
Comprehensive AAV capsid fitness landscape reveals a viral gene and enables machine-guided design
2019 - DOI: 10.1093/molbev/msz004 ↗
Adaptive Landscapes in the Age of Synthetic Biology
2019 - DOI: 10.1002/advs.202306478 ↗
Growth‐Coupled Evolutionary Pressure Improving Epimerases for D‐Allulose Biosynthesis Using a Biosensor‐Assisted In Vivo Selection Platform
2024 - DOI: 10.1101/2023.11.28.569059 ↗
Bioorthogonal Metabolic Labeling of the Virulence Factor Phenolic Glycolipid in Mycobacteria
2023
+ 1 more reference
Detailed panel scores
A progressive and iterative approach (in silico -> minimal validation -> full experiment) is adopted, with clearly defined go/no-go/pivot criteria. This maximises resource efficiency and permits early adjustments.
The hypothesis successfully bridges two powerful conceptual frameworks: Wrightian fitness landscapes and modern chemical biology tools. The proposed use of activity-based probes (ABPs) as a direct, quantitative readout of a molecular phenotype (enzyme activity) to define a synthetic fitness landscape is conceptually elegant and aligns with the 'mechanistic turn' in evolutionary theory.
The hypothesis elegantly links molecular phenotype (enzyme activity) to a selectable cellular trait (fluorescence) via a clever chemical biology tool, creating a direct readout for evolution.
A critical need in pharmaceutical and biotech R&D is addressed: the accelerated optimisation of enzymes and therapeutic targets. The market for industrial enzyme development services is estimated at >$7 billion, with growth driven by biocatalysis.
The hypothesis merges chemical biology (bioorthogonal ABPs), experimental evolution, and flow cytometry in an original manner, creating a potentially generic methodology for quantifying synthetic fitness landscapes. The approach is quantitative and permits real-time observation, which constitutes a clear methodological advantage.
Receive the next SPORE hypotheses
Once or twice a month, in your inbox. No spam, one-click unsubscribe.
Your data stays private. No third-party sharing. GDPR-compliant.